Soroprevalência de Zika e dengue no mundo: uma revisão integrativa da literatura
DOI:
https://doi.org/10.34119/bjhrv6n3-275Keywords:
arbovírus, Zika vírus, vírus da dengue, estudos soroepidemiológicosAbstract
Objetivo: Realizar uma revisão integrativa de estudos de prevalência de dengue e Zika, bem como descrever os testes sorológicos utilizados. Métodos: Mapeamento bibliográfico de estudos publicados entre 2011 e 2021 disponíveis na MEDLINE/Pubmed, BVS/LILACS e SCIELO, utilizando estratégia de busca com termos MESH e DECS. Resultados: A revisão encontrou 106 estudos de soroprevalência de Zika e dengue em quatro dos seis continentes do mundo. Houve um predomínio no uso de testes comerciais das marcas Euroimunn e Panbio para pesquisa sorológica dos vírus Zika e dengue, respectivamente. Taxas de soroprevalência de Zika superiores a 60% foram encontradas na América do Sul e Oceania. E taxas superiores a 90% de soroprevalência de dengue foram descritas na América do Sul e Ásia. Considerações finais: As infecções pelos vírus Zika e dengue tiveram ampla propagação em países tropicais, principalmente na América Latina, no entanto, essa disseminação foi desigual, permanecendo grandes populações ainda suscetíveis a novos surtos. Recomenda-se, portanto, que políticas públicas de prevenção e pesquisas para melhoria dos métodos de triagem e diagnóstico, sejam prioridades no controle dessas infecções.
References
ARAÚJO TVB de, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. The Lancet Infectious Diseases, 2016; 16(12): 1356-63.
BALMASEDA A, et al. Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proceedings of the National Academy of Sciences, 2017; 114: 8384-89. doi:10.1073/pnas.1704984114.
BHATT S, et al. The global distribution and burden of dengue. Nature, 2013; 496(7446): 504-7.
BHAUMIK S. Study estimates 390 million dengue cases a year in world, with India having highest burden. BMJ, 2013; 346:f2339. doi: 10.1136/bmj.f2339. PMID: 23585073.
BOURNAZOS S, et al. Antibody fucosylation predicts disease severity in secondary dengue infection. Science, 2021; 372(6546): 1102-05. doi: 10.1126/science.abc7303.
BRAGA IA, VALLE D. Aedes aegypti: histórico do controle no Brasil. Epidemiologia e Serviços de Saúde, 2007; 16(2): 113-118, 2007.
BRITO CAA de, CORDEIRO M.T. One year after the Zika virus outbreak in Brazil: from hypotheses to evidence. Revista da Sociedade Brasileira de Medicina Tropical, 2016; 49(5): 537-543.
CARABALI M. Spatiotemporal distribution and socioeconomic disparities of dengue, chikungunya and Zika in two Latin American cities from 2007 to 2017. Tropical Medicine & International Health, 2021; 26(3): 301-15. doi: 10.1111/tmi.13530.
CARVALHO FD, MOREIRA LA. Why is Aedes aegypti Linnaeus so successful as a species? Neotropical Entomology, 2017: 46(3): 243-255.
CENTERS FOR DISEASE CONTROL AND PREVENTION - CDC. New Zika and Dengue testing guidance 2019. Disponível em: https://www.cdc.gov/zika/hc-providers/testing-guidance.html. Acessado em: 11 de fevereiro de 2023.
CHARLIER C et al. Arboviruses and pregnancy: maternal, fetal, and neonatal effects. The Lancet Child & Adolescent Health, 2017; 1(2): 134-46.
CUNZE S et al. Vector distribution and transmission risk of the Zika virus in South and Central America. PeerJ, 2019; 7(11): 7920.
dos SANTOS AL et al. Achados imaginológicos de ressonância magnética em crianças com microcefalia por Vírus Zika Congênito: revisão de literatura. Brazilian Journal of Health Review, 2021, 4(5), 20339–20352. doi: 10.34119/bjhrv4n5-148.
HARAPAN H et al. Dengue: A Minireview. Viruses, 2020; 12(8): 829. doi: 10.3390/v12080829.
KERKHOF K et al. Reliable serological diagnostic tests for arboviruses: feasible or utopia? Trends in Microbiology, 2020; 28(4): 276-92. doi: 10.1016/j.tim.2019.11.005.
KUPER H et al. The association of depression, anxiety, and stress with caring for a child with Congenital Zika Syndrome in Brazil; Results of a cross-sectional study. PLoS Neglected Tropical Diseases, 2019; 13(9): e0007768.
LIMA MDRQ et al. The inability of a dengue NS1 ELISA to detect Zika infections. Scientific Reports, 2019; 9(18596). doi: 10.1038/s41598-019-55160-4.
MARTELLI CMT et al. Economic impact of Dengue: multicenter study across four Brazilian regions. PLos Neglected Tropical Diseases, 2015, 9(9): e0004042.
MELO B et al. A herança do Zika Vírus: quais as consequências após dois anos do principal surto no Brasil? Brazilian Journal of Health Review, 2021, 4(3), 12503–12507. doi: 10.34119/bjhrv4n3-223.
MENEZES AMF et al. Perfil epidemiológico da dengue no Brasil entre os anos de 2010 à 2019. Brazilian Journal of Health Review, 4(3), 2021, 13047–13058. doi: 10.34119/bjhrv4n3-259
MINISTÉRIO DA SAÚDE - MS. Monitoramento dos casos de arboviroses urbanas transmitidas pelo Aedes aegypti (dengue, chikungunya e zika). Situação epidemiológica da síndrome congênita associada à infecção pelo vírus Zika: Brasil, 2015 a 2022, até a SE 31. 2022. Semanas Epidemiológicas. Boletim Epidemiológico, 53(35), 2022. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2022/boletim-epidemiologico-vol-53-no35/view . Acessado em: 11 de fevereiro de 2023.
MULIK V. Dengue in pregnancy: Review article. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2021; 261: 205-210. doi: 10.1016/j.ejogrb.2021.04.035.
MUSSO, D et al. Zika virus: following the path of dengue and chikungunya? The Lancet, 2015; 8(386): 243-34. doi: 10.1016/S0140-6736(15)61273-9.
MUSSO D, GUBLER, DJ. Zika virus. Clinical Microbiology Reviews, 2016; 29(3): 487-524.
MUSSO D et al. Zika virus infection - after the pandemic. New England Journal of Medicine, 2019; 381(15): 1444-57.
NETTO EM et al. High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks. American Society for Microbiology, 2017; 8. doi: 10.1128/mBio.01390-17
NUJUM ZT et al. Seroprevalence of dengue infection in pregnant women and placental antibody transfer. Medical Journal Armed Forces India, 2019; 75(1): 90-95.
NUNES PS et al. Zika virus infection and microcephaly: spatial analysis and socio-environmental determinants in a region of high Aedes aegypti infestation in the Central-West Region of Brazil. BMC Infectious Diseases, 2021; 21:1107.
OLAWOYIN O, KRIBS C. Coinfection, altered vector infectivity, and antibody-dependent enhancement: the dengue-zika interplay. Bulletin of Mathematical Biology, 2020; 82(1): 13. doi:10.1007/s11538-019-00681-2.
PETERS R, STEVENSON M. Zika virus diagnosis: challenges and solutions. Clinical Microbiology and Infection, 2019; 25 (2): 142-146, 2019.
PETERSEN L. R et al. Zika Virus. New England Journal of Medicine, 2016b; 374(16): 1552-63.
PRIYAMVADA L. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Emerging Microbes & Infections, 2017; 6(5): e33. doi: 10.1038/emi.2017.42.
QUEIROZ ERDS, MEDRONHO RA. Spatial analysis of the incidence of Dengue, Zika and Chikungunya and socioeconomic determinants in the city of Rio de Janeiro, Brazil. Epidemiology and Infection, 2021; 149: e188. doi:10.1017/S0950268821001801
RABE IB et al. Interim guidance for interpretation of Zika virus antibody test results. Morbidity and Mortality Weekly Report, 2016; 65(21): 543-46.
RASMUSSEN SA et al. Zika virus and birth defects - reviewing the evidence for causality. New England Journal of Medicine, 2016; 374(20): 1981-87.
SANTOS J, MENESES BM. An integrated approach for the assessment of the Aedes aegypti and Aedes albopictus global spatial distribution, and determination of the zones susceptible to the development of Zika virus. Acta Tropica, 2017; 168:80-90.
SHARMA A, LAL SK. Zika Virus: Transmission, detection, control, and prevention. Frontiers in Microbiology, 2017; 8(110).
SHARP TM et al. Dengue and zika virus diagnostic testing for patients with a clinically compatible illness and risk for infection with both viruses. MMWR Recommendations and Reports, 2019; 68(1): 1-10,. doi: 10.15585/mmwr.rr6801a1.
STANAWAY JD et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. The Lancet Infectious Diseases, 2016; 16: 712-23.
THEEL ES, HATA DJ. Diagnostic testing for Zika virus: a postoutbreak update. Journal of Clinical Microbiology, 2018; 56(4): e01972-17. doi: 10.1128/JCM.01972-17.
VEDOVELLO D et al. Detection of Zika virus in paired urine and amniotic fluid samples from symptomatic and asymptomatic women and their babies during a disease outbreak: association with neurological symptoms in newborns. Journal of Neurovirology, 2020; 26(1): 70-76.
World Health Organization - WHO. Pregnancy management in the context of Zika virus infection (WHO/ZIKV/MOC/16.2 Rev.1). 2016. 14 p. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/204520/WHO_ZIKV_MOC_16.2_eng.pdf;jsessionid=F0C58B855FE2323BE8723BA99F86F6F8?sequence=1. Acessado em: 11 de fevereiro de 2023.
World Health Organization - WHO. Zika epidemiology update. Disponível em: <https://www.who.int/emergencies/diseases/zika/epidemiology-update/en/>. Acessado em: 11 de fevereiro de 2023.
